Arctic Therapeutics

Iceland
Reykjavík, Capital Region, Iceland, 102

Company profile

Arctic Therapeutics company profile

Arctic Therapeutics focuses on identifying genetic causes of major diseases and helping develop effective treatments for patients. Arctic Therapeutics aims to mitigate major risks linked to conventional drug development through the use of bioinformatics and artificial intelligence, ultimately lowering expenses and expediting the time to market. Arctic Therapeutics' research and development efforts are spearheaded by a group of global specialists in genetics, genomics, immunology, bioinformatics, and drug development

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2015-01-01, Year

Headquarters

Postal code
102
Country code
IS
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
3
Total equity funding
$38.2M
Last funding
Series A / $27.6M / 2025-01-21
Last equity funding
Series A / $27.6M
Investors
6
Lead investors
1
Founders
2
Articles
16

Founders and investors

Founders

Hakon HakonarsonIvar Hakonarson

Lead investors

European Innovation Council

Investors

Cerebrum DAOEIC AcceleratorEuropean Innovation CouncilNancy Lurie Marks Family FoundationSanos Clinic